Pierludovico Moro’s Post

Moving forward

Just imagine... evaluating brain perfusion on arterial spin labeling images was just one click away. Watch this video to see how we implemented Explore ASL in our mTRIAL platform to facilitate and standardize your next clinical study on neurodegenerative diseases. Stay tuned to see how easy your data reaches mTRIAL. Contact us for more information on ASL imaging and analysis. #Alzheimer #aspiremri #mediri #clinicaltrial #research #dementia #mri

Epilepsy is a neurological condition, often complex to diagnose and treat. For critically ill infants in the NICU, PICU, and CVICU, timely and accurate diagnosis of epilepsy is critical for effective treatment and care. Research shows that WGS/WES provides higher diagnostic yields compared to other methods, particularly for early-onset epilepsy and specific clinical features, providing substantial benefits for children aged 2-3 years. Baylor Genetics' WES and WGS offerings aim to end the diagnostic odyssey for patients with unexplained epilepsy, enabling informed patient care. Want to learn more: https://bit.ly/4bWsOCt #ThinkBG #BGreat #Epilepsy

Are you tired of all your neuropathy consultations going the same exact way? Explore advanced treatment options with the board-certified doctors at BEST. We utilize modern approaches to help patients find relief from neuropathy and chronic pain. Visit our new article to learn more. https://lnkd.in/g-ReXc36 #neuropathy #nervepain #nervedamage #neuropathytreatment #spinalcordstiulator #BESTHealthSystem

Identifying stroke risk factors, such as chronic loneliness, is critical for improving health outcomes for stroke patients. Loneliness can look different for everyone, making a diagnosis elusive for on-site care teams who lack support from neurological experts. Read Dr. Jones' recent interview with Georgia Public Broadcasting and see why hospitals with neurology specialists can more readily identify patients with elevated stroke risks. https://lnkd.in/gZm2Jyt7

Nerve Repair & Regeneration Market : Size, Share & Trends 👉 Download PDF Brochure: https://lnkd.in/d7fbRRR9 The global nerve repair market is experiencing robust growth! 📊💡 Estimated at $6.5 billion in 2022, it is projected to soar to $11.6 billion by 2027, with an impressive CAGR of 12.1%. 📈 Key Market Drivers 🚀 - Rising Prevalence of #Neurological Disorders: Increasing need for effective nerve repair solutions. - #AgingPopulation: Growing geriatric demographic contributing to market demand. - High Incidence of #NerveInjuries: Driving innovation and treatment advancements. - Government Support: Boosting research and development in neurologic disorders. Prominent players in the nerve repair market include Medtronic, Boston Scientific , and Abbott (US). #NerveRepair #HealthcareInnovation #MarketGrowth #NeurologicalDisorders #AgingPopulation #NerveInjuries #MedicalResearch #MarketTrends #HealthcareTech

A new study published in the Journal of Neurological Sciences has highlighted the negative impact #SteroidToxicity has on patient quality of life and identifed toxicities most relevant to them. Read on to find out how the impact has been quantified by data and even further illuminated by comments made by the patients themselves: https://hubs.li/Q02nxFKf0 #ClinicalStudies #ClinicalResearch #SteritasGTI #Glucocorticoids #Steroids #PatientImpact #PatientCare #Healthcare #QualityofLife

A new study found that patients who used GLP-1 agonists had a 30% lower risk of developing dementia compared to those who used sulfonylureas, and a 23% lower risk compared to those who used DPP-4 inhibitors. Credit: Neuroscience News Study Scope: Followed over 88,000 older adults with type 2 diabetes for up to ten years. Clinical Implications: Findings can help doctors make informed medication choices for diabetes patients. #Alzheimers #dementia #glp1 #Clinicalresearchnaples

Embrace a new chapter in managing Multiple Sclerosis. Life-altering, yes–but now, patients have a spectrum of choices in drugs and treatments. Dive into the possibilities with Dr. Jessica Stulc: https://lnkd.in/g2HzYE3r #MSAwareness #NeurologyCare #MPLS #NeurologyNow

In #Sweden, the patients in this study would have been diagnosed with ”Functional Neurological Disorder” or ”Burn-out Depression”, or both. No one has any interest in neurological disease that demands more resources (testing & imaging) to diagnose, and lacks big-pharma incentives for drug developments. These patients are denied further evaluation and are then claimed by the psychiatry- and rehab health care industry. ”The ultrastructural damage of the collagen fibrils of the MDBs was distinct in patients with EDS, indicating a pathological mechanical laxity. In patients with EDS, ultrasound revealed increased cardiac pulsatory motion and irregular displacement of the spinal cord during head movements. Laxity of spinal cord suspension ligaments and the associated spinal cord motion disorder are possible pathogenic factors for chronic neck pain and headache in patients with EDS but without radiologically proven CCI.” https://lnkd.in/dmcTSjZx